Questions remain as FDA opens submissions for new priority voucher program
Regulatory NewsJoanne S. Eglovitch
Government/legislationLeadershipPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsJoanne S. EglovitchGovernment/legislationLeadershipPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)